Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

The publication summarises the main results showing that at least 20% of cases of severe pneumonia after SARS-CoV-2 infection are explained by genetic and immunological anomalies.

Funded by the Horizon Europe programme, RBDCOV will test the efficacy, tolerability, and safety of the vaccine against the different variants of COVID-19 using a recombinant protein.

The project "I have PID. I'm an adult and I'm not alone" offers telematic sessions to improve the emotional well-being of adult patients with this type of disease.

This year, the Vall d'Hebron team has participated in the publication of three articles to understand the 2016 enterovirus A71 (EV-A71) outbreak in Catalonia and the follow-up of non-polio enteroviruses today.

Vall d'Hebron and the Barcelona PID Foundation are back with Bufa la Bombolla campaign

Within the framework of the project “Cooperative Cohort COVID-19”, a mobile application will allow citizens to transfer their data under certain conditions and thus actively collaborate in research projects.

The associations have donated €32,130 towards the project entitled “Tinc una IDP; No estic sol” [“I have a PID; I’m not alone”]

The team will carry out a project that will optimize the use of immunoglobulins as a treatment in paediatric patients with primary or secondary immunodeficiencies.